2014 annual financial data

Alnylam Pharmaceuticals 2014 Net margin

Direct answer

Net margin was -712.79%.

Operating income was -404.98M USD and net income was -360.4M USD.
Operating cash flow was -165.64M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
50.56M USD
Operating income
-404.98M USD
Net income
-360.4M USD
Operating cash flow
-165.64M USD